Literature DB >> 17224598

Canadian guidelines on sexually transmitted infections, 2006.

Noni MacDonald1, Tom Wong.   

Abstract

Mesh：

Year:  2007        PMID： 17224598      PMCID： PMC1764798          DOI： 10.1503/cmaj.061616

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Macrolide resistance in Treponema pallidum in the United States and Ireland.

Authors:  Sheila A Lukehart; Charmie Godornes; Barbara J Molini; Patricia Sonnett; Susan Hopkins; Fiona Mulcahy; Joseph Engelman; Samuel J Mitchell; Anne M Rompalo; Christina M Marra; Jeffrey D Klausner
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

2.  Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.

Authors:  Samuel J Mitchell; Joseph Engelman; Charlotte K Kent; Sheila A Lukehart; Charmie Godornes; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2005-12-28       Impact factor: 9.079

3.  Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.

Authors:  Gabriele Riedner; Mary Rusizoka; Jim Todd; Leonard Maboko; Michael Hoelscher; Donan Mmbando; Eleuter Samky; Eligius Lyamuya; David Mabey; Heiner Grosskurth; Richard Hayes
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

4.  Treponema pallidum macrolide resistance in BC.

Authors:  Muhammad G Morshed; Hugh D Jones
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

5.  Gonorrhea reinfection among sexually transmitted disease clinic attendees in Baltimore, Maryland.

Authors:  Kyle T Bernstein; Jonathan Zenilman; Glen Olthoff; Vincent C Marsiglia; Emily J Erbelding
Journal:  Sex Transm Dis       Date:  2006-02       Impact factor: 2.830

6.  Predictors of gonorrhea reinfection in a cohort of sexually transmitted disease patients in Alberta, Canada, 1991-2003.

Authors:  Prithwish De; Ameeta E Singh; Tom Wong; Angela Kaida
Journal:  Sex Transm Dis       Date:  2007-01       Impact factor: 2.830

7.  Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study.

Authors:  W L Whittington; C Kent; P Kissinger; M K Oh; J D Fortenberry; S E Hillis; B Litchfield; G A Bolan; M E St Louis; T A Farley; H H Handsfield
Journal:  Sex Transm Dis       Date:  2001-02       Impact factor: 2.830

8.  Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening.

Authors:  Cornelis A Rietmeijer; Rogier Van Bemmelen; Franklyn N Judson; John M Douglas
Journal:  Sex Transm Dis       Date:  2002-02       Impact factor: 2.830

9.  A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis.

Authors:  Edward W Hook; David H Martin; Joan Stephens; Babara S Smith; Kim Smith
Journal:  Sex Transm Dis       Date:  2002-08       Impact factor: 2.830
  9 in total
  4 in total

1.  Adolescent medicine: A new paediatric subspecialty in Canada.

Authors:  Debra K Katzman; Jean-Yves Frappier; Eudice Goldberg
Journal:  Paediatr Child Health       Date:  2008-01       Impact factor: 2.253

2.  Upsurge of chlamydial reinfection in a large Canadian city: an indication of suboptimal chlamydia screening practices?

Authors:  Mélissa Généeux; Pascale Leclerc; Lucie Bédard; Robert Allard
Journal:  Can J Public Health       Date:  2010 Sep-Oct

3.  A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025.

Authors:  Daniel Chemtob; Dan Gandacu; Zohar Mor; Itamar Grotto; Emilia Anis; Elliot Rosenberg
Journal:  Isr J Health Policy Res       Date:  2017-04-19

4.  Knowledge and acceptability of Chlamydia trachomatis screening among pregnant women and their partners; a cross-sectional study.

Authors:  Monique T R Pereboom; Evelien R Spelten; Judith Manniën; G Ingrid J G Rours; Servaas A Morré; François G Schellevis; Eileen K Hutton
Journal:  BMC Public Health       Date:  2014-07-09       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.